by [email protected] | May 7, 2020 | Cardiovascular, Endocrine, Publication
Abstract Authors: Gregory Y H Lip, Allison V Keshishian, Amiee L Kang, Xiaoyan Li, Amol D Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Anagha Nadkarni, Xianying Pan, Manuela Di Fusco, Alessandra B Garcia Reeves, Huseyin Yuce, Steven B...
by [email protected] | Nov 13, 2019 | Cardiovascular, Publication
Abstract Authors: Ritam Chowdhury, Jessica Franchino-Elder, Li Wang, Huseyin Yuce, Cheng Wang, Brian O Hartaigh Aims: Non-valvular atrial fibrillation (NVAF) prevalence increases with age. Hence, evaluating the economic burden among older-aged patients is vital. This...
by [email protected] | Jun 14, 2019 | Cardiovascular, Publication
Abstract Authors: Kiran Gupta, Jeffrey Trocio, Allison Keshishian, Qisu Zhang, Oluwaseyi Dina, Jack Mardekian, Anagha Nadkarni, Thomas C Shank Background: Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at least non-inferior to warfarin...
by [email protected] | Jun 2, 2019 | Cardiovascular, Publication, Pulmonary
Abstract Background Rivaroxaban, a fixed-dose oral direct factor Xa inhibitor, does not require continuous monitoring and thus reduces the hospital stay and economic burden in low-risk pulmonary embolism (LRPE) patients. Study Question What is the effectiveness of...
by [email protected] | May 19, 2019 | Cardiovascular, Publication
Abstract Authors: Shrestha S, Baser O, Kwong WJ. Background: Non-vitamin K antagonist direct oral anticoagulants (DOACs) are fixed-dose regimens indicated for stroke prevention in nonvalvular atrial fibrillation (NVAF) patients. Dose adjustment is necessary among...
by [email protected] | May 15, 2019 | Cardiovascular
Abstract Authors: Deitelzweig S, Keshishian A, Li X, Kang A, Dhamane A, Luo X, Balachander N, Rosenblatt L, Mardekian J, Pan X, Nadkarni A, Di Fusco M, Garcia Reeves AB, Yuce H, Lip GYH Objectives: Older adult patients are underrepresented in clinical trials...
